Drug Profile
Darbepoetin alfa biosimilar - Dr Reddy's
Alternative Names: CrespLatest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator Dr Reddys Laboratories
- Class Antianaemics; Recombinant erythropoietins
- Mechanism of Action Erythropoiesis stimulants; Erythropoietin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Anaemia
Most Recent Events
- 31 Dec 2010 Launched during 2010 for Anaemia (chemotherapy-induced) in India (SC)
- 31 Dec 2010 Launched during 2010 for Anaemia in India (SC)